SuperworthErnexa Therapeutics shares outstanding ERNA
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 1.2M
- On a year earlier
- +471.5%
- more shares
Ernexa Therapeutics had 1.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 471.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 329.4K | +224% |
| FY2024 | 101.8K | +605% |
| FY2023 | 14.4K | +49% |
| FY2022 | 9.7K | +40% |
| FY2021 | 6.9K | +195% |
| FY2020 | 2.4K | +1121% |
| FY2019 | 193 | +1% |
| FY2018 | 191 | +14% |
| FY2017 | 167 | +20% |
| FY2016 | 140 | +14% |
| FY2015 | 123 | +0% |
| FY2014 | 122 | +23% |
| FY2013 | 100 | +104597% |
| FY2012 | 0 | +18% |
| FY2011 | 0 | +0% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.2M | +471% | |
| Q1 FY26 | 792K | +458% | |
| Q4 FY25 | 329.4K | +224% | |
| Q3 FY25 | 329K | +2179% | |
| Q2 FY25 | 207K | +1334% | |
| Q1 FY25 | 142K | +884% | |
| Q4 FY24 | 101.8K | +605% | |
| Q3 FY24 | 14.4K | +0% | |
| Q2 FY24 | 14.4K | +2% | |
| Q1 FY24 | 14.4K | +6% | |
| Q4 FY23 | 14.4K | +49% | |
| Q3 FY23 | 14.4K | +84% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Ernexa Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.